Appraised Value of 3D Echocardiography Combined with the Triglyceride–Glucose Index to Evaluate the Long-Term Prognosis of Patients after Percutaneous Coronary Intervention
DOI:
https://doi.org/10.59958/hsf.6881Keywords:
3D echocardiography, triglyceride–glucose index, percutaneous coronary intervention, long-term prognosisAbstract
Objective: This study analyzed three-dimensional echocardiography (3DE) combined with the triglyceride–glucose (TYG) index to evaluate the long-term prognosis of patients after percutaneous coronary intervention (PCI). Methods: The clinical data of 102 patients who were treated with PCI after admission to our hospital from January 2020 to December 2020 were retrospectively analyzed. All the patients were followed up for 24 months to evaluate their long-term prognosis. The occurrence of cardiovascular and cerebrovascular events in all the patients was recorded. Cardiovascular and cerebrovascular events refer to a series of diseases or conditions of the heart and the cerebrovascular system, including sudden cardiac death. Patients with cardiovascular events were assigned to the exposed group, while those without cardiovascular events were included in the nonexposed group. The left ventricular end-diastolic volume (LVEDV), left ventricular end-systolic volume (LVESV), left ventricular mass index (LVMI), left ventricular remodeling index (LVRI), left ventricular ejection fraction (LVEF), standard deviation of time to peak of left ventricular 16 segments (Tmsv16-SD), maximum time difference (Tmsv16-Dif), and difference between the 3DE index and the TYG index were collected. Logistic regression analysis was performed on the indicators with differences to analyze the influencing factors of the long-term prognosis of patients after PCI. The receiver operating characteristic (ROC) curve was drawn. The sensitivity, specificity, area under the curve (AUC), and Youden index were calculated. The best predictive cutoff value was determined. The predictive value of the 3DE index and the TYG index, either alone or in combination, was observed for long-term prognosis after PCI. The relationship between the 3DE index and the TYG index was explored. Result: The 2-year follow-up results showed that 22 patients experienced cardiovascular events, and they were included in the exposed group, accounting for 21.57%. The remaining 80 patients without cardiovascular events were included in the nonexposed group, accounting for 78.43%. A significant difference was found in creatinine (Cr), high-density lipoprotein cholesterol (HDL-C), LVEDV, LVESV, LVMI, LVRI, LVEF, Tmsv16-SD, Tmsv16-Dif, and the TYG index between the exposed group and nonexposed group (p < 0.05). Cr, HDL-C, LVEDV, LVESV, LVMI, Tmsv16-SD, Tmsv16-Dif, and the TYG index in the exposed group were higher than those in the nonexposed group (p < 0.05). The exposed group also had lower LVRI and LVEF than the nonexposed group (p < 0.05). Logistic regression analysis of the indicators with differences showed that Cr, HDL-C, LVEDV, LVESV, LVMI, LVRI, LVEF, Tmsv16-SD, Tmsv16-Dif, and the TYG index were the major factors that affect the long-term prognosis of patients after PCI, with odds ratio values >1. Correlation analysis showed that the TYG index was positively correlated with LVEDV, LVESV, LVMI, Tmsv16-SD, Tmsv16-Dif, and the TYG index (r = 0.565, 0.678, 0.696, 0.702, 0.788, 0.804, p < 0.05). Moreover, it was negatively correlated with LVRI and LVEF (r = –0.580, –0.674, p < 0.05). The sensitivity and specificity of the 3DE index combined with the TYG index in predicting long-term prognosis after PCI were 0.818 and 0.950, respectively, which were significantly higher than those of the 3DE index or the TYG index alone. The Youden index was 0.768, the AUC value was 0.922, and the optimal threshold was 36.64. Conclusion: The 3DE index and the TYG index were influencing factors for the long-term prognosis of patients after PCI, and a correlation existed between the 3DE index and the TYG index. The 3DE index combined with the TYG index can improve the predictive efficiency of the long-term prognosis of patients after PCI.
References
Zhu Y, Liu K, Chen M, Liu Y, Gao A, Hu C, et al. Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents. Cardiovascular Diabetology. 2021; 20: 137.
Luo E, Wang D, Yan G, Qiao Y, Liu B, Hou J, et al. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention. Cardiovascular Diabetology. 2019; 18: 150.
Zhao X, Wang Y, Chen R, Li J, Zhou J, Liu C, et al. Triglyceride glucose index combined with plaque characteristics as a novel biomarker for cardiovascular outcomes after percutaneous coronary intervention in ST-elevated myocardial infarction patients: an intravascular optical coherence tomography study. Cardiovascular Diabetology. 2021; 20: 131.
Ma X, Dong L, Shao Q, Cheng Y, Lv S, Sun Y, et al. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome. Cardiovascular Diabetology. 2020; 19: 31.
Li J, Ren L, Chang C, Luo L. Triglyceride-Glukose Index Predicts Adverse Events in Patients with Acute Coronary Syndrome: A Meta-Analysis of Cohort Studies. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones et Metabolisme. 2021; 53: 594–601.
Özkalaycı F, Karagöz A, Karabay CY, Tanboga İH, Türkyılmaz E, Saygı M, et al. Prognostic value of triglyceride/glucose index in patients with ST-segment elevation myocardial infarction. Biomarkers in Medicine. 2022; 16: 613–622.
Mao Q, Zhou D, Li Y, Wang Y, Xu SC, Zhao XH. The Triglyceride-Glucose Index Predicts Coronary Artery Disease Severity and Cardiovascular Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome. Disease Markers. 2019; 2019: 6891537.
Huang R, Lin Y, Ye X, Zhong X, Xie P, Li M, et al. Triglyceride-glucose index in the development of heart failure and left ventricular dysfunction: analysis of the ARIC study. European Journal of Preventive Cardiology. 2022; 29: 1531–1541.
Gao S, Ma W, Huang S, Lin X, Yu M. Impact of triglyceride-glucose index on long-term cardiovascular outcomes in patients with myocardial infarction with nonobstructive coronary arteries. Nutrition, Metabolism, and Cardiovascular Diseases: NMCD. 2021; 31: 3184–3192.
Farmakis D, Andrikopoulos G, Giamouzis G, Giannakoulas G, Poulimenos L, Skalidis E, et al. Practical Recommendations for the Diagnosis and Medical Management of Stable Angina: An Expert Panel Consensus. Journal of Cardiovascular Pharmacology. 2019; 74: 308–314.
Mirshafiei H, Darroudi S, Ghayour-Mobarhan M, Esmaeili H, AkbariRad M, Mouhebati M, et al. Altered triglyceride glucose index and fasted serum triglyceride high-density lipoprotein cholesterol ratio predict incidence of cardiovascular disease in the Mashhad cohort study. BioFactors (Oxford, England). 2022; 48: 643–650.
Baydar O, Kilic A, Okcuoglu J, Apaydin Z, Can MM. The Triglyceride-Glucose Index, a Predictor of Insulin Resistance, Is Associated with Subclinical Atherosclerosis. Angiology. 2021; 72: 994–1000.
Cetin Sanlialp S, Nar G, Nar R. Relationship between circulating serum omentin-1 levels and nascent metabolic syndrome in patients with hypertension. Journal of Investigative Medicine: the Official Publication of the American Federation for Clinical Research. 2022; 70: 780–785.
Biswas AK, Haque T, Banik D, Choudhury SR, Khan SR, Malik FTN. Identification of significant coronary artery disease in patients with non-ST segment elevation acute coronary syndrome by myocardial strain analyses using three dimensional speckle tracking echocardiography. Echocardiography (Mount Kisco, N.Y.). 2018; 35: 1988–1996.
Fei M, Li M, Ran H, Sheng Z, Dong J, Zhang P. Four-dimensional quantification on left atrial volume-strain in coronary heart disease patients without regional wall motion abnormalities: Correlation with the severity of coronary stenosis. Echocardiography (Mount Kisco, N.Y.). 2022; 39: 758–767.
Berbarie RF, Dib E, Ahmad M. Stress echocardiography using real-time three-dimensional imaging. Echocardiography (Mount Kisco, N.Y.). 2018; 35: 1196–1203.
Hidayet Ş, Yağmur J, Karaca Y, Bayramoğlu A, Yolbaş S, Hidayet E, et al. Assessment of left atrial volume and function in patients with Sjögren's syndrome using three-dimensional echocardiography. Echocardiography (Mount Kisco, N.Y.). 2020; 37: 715–721.
Nguyen VP, Qin A, Kirkpatrick JN. Three-dimensional echocardiography of mechanical circulatory support devices. Echocardiography (Mount Kisco, N.Y.). 2018; 35: 2071–2078.
Inciardi RM, Galderisi M, Nistri S, Santoro C, Cicoira M, Rossi A. Echocardiographic advances in hypertrophic cardiomyopathy: Three-dimensional and strain imaging echocardiography. Echocardiography (Mount Kisco, N.Y.). 2018; 35: 716–726.
Kemaloğlu Öz T, Fiore C, Gürol T, Şener T, Soylu Ö, Dağdeviren B, et al. Usefulness of live/real time three/four-dimensional transesophageal echocardiography in the percutaneous closure of an iatrogenic aorto-right ventricular fistula. Echocardiography (Mount Kisco, N.Y.). 2018; 35: 410–412.
Murray CSG, Salama AY, Akdogan RE, Harb S, Nahar T, Nanda NC. Assessment of tricuspid valve by two- and three-dimensional echocardiography with special reference to percutaneous repair and prosthetic valve implantation procedures. Echocardiography (Mount Kisco, N.Y.). 2018; 35: 1419–1438.
Nemes A, Kormányos Á, Domsik P, Kalapos A, Ambrus N, Lengyel C. Normal reference values of three-dimensional speckle-tracking echocardiography-derived right atrial volumes and volume-based functional properties in healthy adults (Insights from the MAGYAR-Healthy Study). Journal of Clinical Ultrasound: JCU. 2020; 48: 263–268.
Dibbendhu K, Sinha SK, Pradyot T, Razi M, Puneet A, Shishir S, et al. Three Dimensional Echocardiography in Non ST Elevation Acute Coronary Syndrome in North India(3D-EINSTEIN)-A Single Centre Prospective Study. Journal of the Practice of Cardiovascular Sciences. 2019; 5: 94–101.
Ostenfeld E, Werther-Evaldsson A, Engblom H, Ingvarsson A, Roijer A, Meurling C, et al. Discriminatory ability of right atrial volumes with two- and three-dimensional echocardiography to detect elevated right atrial pressure in pulmonary hypertension. Clinical Physiology and Functional Imaging. 2018; 38: 192–199.
Grin L, Laish-Farkash A, Shenhav S, Piltz X, Ganelin L, Rabinovich M, et al. Safety of nifedipine in threatened preterm labor: Investigation by three-dimensional echocardiography. Echocardiography (Mount Kisco, N.Y.). 2018; 35: 1164–1170.
Hani ME. Added value of three‐dimensional transesophageal echocardiography in management of mitral paravalvular leaks. Echocardiography. 2020; 37: 954–964.
Tandon R, Arisha MJ, Nanda NC, Kumar S, Wander GS, Srialluri S, et al. Incremental benefit of three-dimensional transthoracic echocardiography in the assessment of left atrial appendage aneurysm leading to severe extrinsic compression of a coronary artery. Echocardiography (Mount Kisco, N.Y.). 2018; 35: 685–691.
Lv Q, Li M, Li H, Wu C, Dong N, Li Y, et al. Assessment of biventricular function by three-dimensional speckle-tracking echocardiography in clinically well pediatric heart transplantation patients. Echocardiography (Mount Kisco, N.Y.). 2020; 37: 2107–2115.
Ramsdell G, Davies S, Ailawadi G, Singh KE. An unusual appearance of a large mitral valve cleft within a prolapsing segment diagnosed by three-dimensional transesophageal echocardiography. Echocardiography (Mount Kisco, N.Y.). 2018; 35: 2124–2126.
Peters AC, Gong FF, Rigolin VH. Three-dimensional echocardiography for the assessment of the tricuspid valve. Echocardiography (Mount Kisco, N.Y.). 2020; 37: 758–768.
Ekmekci C, Cabuk AK. Comparison of left ventricular subclinical systolic dysfunction between hemodialysis patients and renal transplant recipients using real time three-dimensional echocardiography. Echocardiography (Mount Kisco, N.Y.). 2022; 39: 708–716.
